These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29522204)

  • 1. Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations.
    Hou Y; Luo YB; Dai T; Shao K; Li W; Zhao Y; Lu JQ; Yan C
    J Neuropathol Exp Neurol; 2018 May; 77(5):395-404. PubMed ID: 29522204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria.
    Challa S; Jakati S; Uppin MS; Kannan MA; Liza R; Murthy Jagarlapudi MK
    Neurol India; 2018; 66(3):767-771. PubMed ID: 29766941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.
    Sun C; Tian X; Yang H; Yang H; Li S; Jiang W; Peng Q; Wang G; Lu X
    Clin Exp Rheumatol; 2024 Feb; 42(2):302-308. PubMed ID: 38488095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyositis: an overdiagnosed entity.
    van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
    Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement.
    Liu M; Hou Y; Dai T; Lv J; Li W; Zhao Y; Fang Q; Yan C
    J Clin Neurosci; 2019 Jul; 65():46-53. PubMed ID: 31060889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Clinical Development of Sporadic Inclusion Body Myositis and Polymyositis With Mitochondrial Pathology: A Single-Center Retrospective Analysis.
    Winkler M; von Landenberg C; Kappes-Horn K; Neudecker S; Kornblum C; Reimann J
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1060–1067. PubMed ID: 34643702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
    Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
    J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L; Blumbergs PC; Manavis J; Limaye VS
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients.
    Danielsson O; Lindvall B; Gati I; Ernerudh J
    J Rheumatol; 2013 Jul; 40(7):1173-82. PubMed ID: 23637317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
    Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
    Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The geoepidemiology of autoimmune muscle disease.
    Prieto S; Grau JM
    Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
    Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
    Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.